NEW YORK, May 9, 2011 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New
Treatments
http://www.reportlinker.com/p0490687/US-Rheumatoid-Arthritis-Market-Assessment-of-Biologics-and-New-Treatments.html
This research service covers the U.S. rheumatoid arthritis (RA)
market from 2007 to 2017, with 2010 as the base year. Included in
this research service are products currently in the market,
products in development, and patient forecasts. Market challenges,
drivers, and restraints are identified and assessed. Strategic
recommendations are presented to overcome listed industry
challenges. This research service does not include market revenue
forecasts for DMARDs. This research service highlights product
forecasts for biologic products as well as small molecules near
launch.
Table of Contents
Scope
10
Methodology
Methodology
11
Market Introduction
RA Background
13
Epidemiology
14
Risk Factors
15
Diagnosis
16
Treatment Paradigm
17
Patient Outlook
Patient Forecast of RA in the United States
19
RA Patients Requiring Add-on Therapy, Forecast in the United
States
20
Patients Taking Add-on Therapy Forecast in the United States
21
Industry Challenges
23
Current Treatments
28
Key Trends
31
Market Drivers and Restraints
33
Market Drivers
34
Market Analysis and Forecast
‘/>”/>
SOURCE